Clinical Trials Logo

Penile Induration clinical trials

View clinical trials related to Penile Induration.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05871177 Active, not recruiting - Peyronie Disease Clinical Trials

Safety and Efficacy of Intralesional HiLow Hyaluronic Acid in the Treatment of Peyronie's Disease (PD)

Start date: May 5, 2023
Phase: N/A
Study type: Interventional

Prospective, open-label, single-arm, multicentric, pilot clinical study to confirm the safety of HiLow hyaluronic acid sodium salt for intralesional penile injection in patients affected by PD.

NCT ID: NCT05480683 Active, not recruiting - Peyronie Disease Clinical Trials

Pelvic CT With Agatston Calcium Score for Peyronie Disease

Start date: August 4, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to find out how including a CT exam of the penis can help urologists make treatment decisions for patients with calcified Peyronie's disease.

NCT ID: NCT04786106 Active, not recruiting - Peyronie's Disease Clinical Trials

Investigation of Surgery, Collagenase, and Restorex for the Improvement of Peyronie's

iSCRIP
Start date: December 30, 2020
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare key clinical outcomes of collagenase clostridium histolyticum injections versus surgery for the management of Peyronie's Disease.

NCT ID: NCT04771442 Active, not recruiting - Penile Diseases Clinical Trials

Stem Cell Treatment of Peyronie´s Disease.

Start date: September 9, 2022
Phase: Phase 1
Study type: Interventional

Purpose of the project is to investigate if a single injection of autologous stromal vascular fraction into and around plaque is a safe and suitable treatment. Twentythree men > 18 years with Peyronie´s Disease in the chronic phase will be recruited. The operative same-day procedure will be performed in general anaesthesia by a plastic surgeon. Before the patient wake, local anaesthesia is put around the penis. Processed stem cells are injected into the plaque/fibrosis subcutaneously. There will be a follow up at 1, 3, 6, 12 months. It is a pilot study with no randomisation. The group will be compared to a historical control group.

NCT ID: NCT04326465 Active, not recruiting - Peyronies Disease Clinical Trials

Fractionated Carbon Dioxide Laser Therapy for Treatment of Peyronie's Disease

Start date: May 1, 2021
Phase: N/A
Study type: Interventional

This is a pilot study that evaluates the use of Fractional Carbon Dioxide Laser Therapy in the treatment of Peyronie's Disease. Study participants will be assigned to receive Fractional Carbon Dioxide Laser Therapy at 10-15% laser density coverage.